Last Updated on April 10, 2024 by The Health Master
USFDA approval
Global pharmaceutical giant Lupin Limited has achieved a significant milestone with the recent announcement of United State Food and Drugs Administration approval (USFDA approval) for its Abbreviated New Drug Application (ANDA) for eslicarbazepine acetate tablets.
This USFDA approval allows Lupin to market a generic equivalent of Aptiom tablets, a product of Sumitomo Pharma America, Inc., in various strengths ranging from 200 mg to 800 mg.
Understanding Eslicarbazepine Acetate Tablets
Eslicarbazepine acetate tablets are a crucial medication used in the treatment of partial-onset seizures in patients aged 4 and above.
These tablets play a vital role in managing epilepsy, offering patients a means to control their condition and improve their quality of life.
Importance of USFDA Approval
USFDA approval is a significant achievement for any pharmaceutical company.
It signifies rigorous testing and evaluation, ensuring the safety and efficacy of the medication.
For Lupin Limited, this USFDA approval opens doors to a wider market and underscores its commitment to providing high-quality healthcare solutions.
Generic Equivalents
As one of the first ANDA applicants, Lupin Limited may qualify for 180 days of shared generic exclusivity.
This period allows the company to market its generic version of eslicarbazepine acetate tablets without competition, providing an opportunity for market penetration and revenue generation.
Manufacturing at Lupin’s Pithampur Facility
Lupin’s commitment to quality extends to its manufacturing facilities, with the approved product set to be manufactured at its state-of-the-art facility in Pithampur, India.
This facility adheres to stringent quality standards, ensuring the production of safe and effective medications.
Indications for Eslicarbazepine Acetate Tablets
Eslicarbazepine acetate tablets are specifically indicated for the treatment of partial-onset seizures, addressing a critical need in epilepsy management.
By offering multiple strengths, physicians can tailor dosage regimens to individual patient requirements, optimizing treatment outcomes.
Market Insights
The approval of eslicarbazepine acetate tablets represents a significant opportunity for Lupin Limited.
With estimated annual sales of USD 354 million in the US alone, the market potential for this medication is substantial.
Lupin’s entry into this space is poised to drive competition and enhance accessibility for patients.
Future Prospects
Looking ahead, Lupin Limited remains poised for continued growth and innovation.
The approval of eslicarbazepine acetate tablets is just one example of the company’s dedication to advancing healthcare solutions.
With a strong pipeline of products and a global presence, Lupin is well-positioned to shape the future of the pharmaceutical industry.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for Mometasone Furoate Monohydrate Nasal Spray
USFDA Approval granted for Aripiprazole Tablets: Lupin
USFDA approval granted for generic Doxycycline for Injection
USFDA Approval granted for Gabapentin Tablets: Strides
CDSCO approval granted for Plazomicin injection in India
USFDA approval granted for Isosorbide Mononitrate ER Tablets
CDSCO grants dual approval for Trastuzumab Deruxtecan
DTAB’s Recommendations for Labeling of Excipients
Ensuring Ethical Pharmaceutical Marketing Practices: A Comprehensive Analysis
Medical Device recall: USFDA classifies recall of this Medical Device as most serious
Revised Schedule M: The Role of Pharmaceutical Waste Management
Pharma Printers must come under the ambit of Drugs Act
How to stop Fake Medicine Business
Drug alert: 58 out of 1167 samples declared as NSQ in February 2024
Increase in Prices of 800 Essential Medicines Set to Take Effect from April 1
CDSCO’s Move Towards Online Submission of PSURs for Medical Devices
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
